Details for Patent: 11,311,488
✉ Email this page to a colleague
Which drugs does patent 11,311,488 protect, and when does it expire?
Patent 11,311,488 protects AUSTEDO XR and is included in one NDA.
This patent has twenty-four patent family members in eighteen countries.
Recent additions to Drugs Protected by US Patent 11,311,488
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE | 216354 | Feb 17, 2023 | RX | Yes | 11,311,488 | Y | ⤷ Subscribe | U-1995 | TREATMENT OF TARDIVE DYSKINESIA | ||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE | 216354 | Jul 1, 2024 | RX | Yes | 11,311,488 | Y | ⤷ Subscribe | U-1995 | TREATMENT OF TARDIVE DYSKINESIA | ||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE | 216354 | May 29, 2024 | RX | Yes | 11,311,488 | Y | ⤷ Subscribe | U-1995 | TREATMENT OF TARDIVE DYSKINESIA | ||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE | 216354 | Feb 17, 2023 | RX | Yes | 11,311,488 | Y | ⤷ Subscribe | U-3055 | A METHOD OF TREATING HUNTINGTON'S CHOREA | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 11,311,488
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE;ORAL | 216354-001 | Feb 17, 2023 | RX | Yes | No | 11,311,488 | ⤷ Subscribe | Y | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Subscribe | |||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE;ORAL | 216354-001 | Feb 17, 2023 | RX | Yes | No | 11,311,488 | ⤷ Subscribe | Y | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Subscribe | |||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE;ORAL | 216354-002 | Feb 17, 2023 | RX | Yes | No | 11,311,488 | ⤷ Subscribe | Y | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Subscribe | |||
| Teva | AUSTEDO XR | deutetrabenazine | TABLET, EXTENDED RELEASE;ORAL | 216354-002 | Feb 17, 2023 | RX | Yes | No | 11,311,488 | ⤷ Subscribe | Y | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,311,488
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 122596 | ⤷ Subscribe | |||
| Australia | 2021288087 | ⤷ Subscribe | |||
| Australia | 2023204103 | ⤷ Subscribe | |||
| Brazil | 112022025185 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
